Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients - Wikidata - wikimedia - TriplyDB

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients

http://www.wikidata.org/entity/Q33765608

about

Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics The effects of intra-articular resiniferatoxin on monosodium iodoacetate-induced osteoarthritic pain in rats.Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial.Biologic monotherapy in the treatment of rheumatoid arthritis.Safety profile of biological therapies for treating rheumatoid arthritis.Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.Monotherapy with biologic disease-modifying anti-rheumatic drugs in rheumatoid arthritis.Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases

P2860

Q33698000-75D60AF6-F0FE-40FF-8CF5-8DF0D6D71A84 Q33809045-652DEF16-C2B6-416A-9B2A-3DEBAACD72CA Q36488665-7A7121F0-099B-4D2D-B443-871D79F1E522 Q38375620-4A2B9EEB-4F9F-4B2D-BE39-69A58F5A8382 Q38510023-76E298BD-0DEB-4334-ADBE-7E22A8C3D1A9 Q38665700-3C5AF0A7-3578-41D4-A74D-5526124F14A1 Q38827889-024B5DFC-24F6-4246-B3BC-92474E2B1007 Q38828876-969EBDCC-DE08-4919-9579-BEBBC59677BF Q41645710-0F8CAE21-C92D-48BD-8473-E1E8D4921B45 Q58750029-60B12D77-917F-4E86-A584-D90187E6F5DE

P2860

Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patients

http://www.wikidata.org/entity/Q33765608

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Rituximab in patients with rhe ...... tional study in 2,484 patients

@ast

Rituximab in patients with rhe ...... tional study in 2,484 patients

@en

type

label

Rituximab in patients with rhe ...... tional study in 2,484 patients

@ast

Rituximab in patients with rhe ...... tional study in 2,484 patients

@en

prefLabel

Rituximab in patients with rhe ...... tional study in 2,484 patients

@ast

Rituximab in patients with rhe ...... tional study in 2,484 patients

@en

P1433

Q33765608-006F8FE1-4FD8-4356-BD46-0A5565257467

P1476

Q33765608-C140F141-58A4-45E3-ADDD-EE75BF3E7C6D

P2093

Q33765608-005E6307-57E2-48BA-955E-7576D34CB335

Q33765608-698ED1AD-4AC1-4E66-B06F-B5794528DE5D

Q33765608-6BC65075-8A1D-4FCF-8622-3C3CC35ABD85

Q33765608-7D783CA8-AD74-4F0C-86A3-D9C64A7E3E49

Q33765608-9C4E7F57-4242-4544-8512-FC6386981BA9

Q33765608-C7C96DB2-845F-4E69-B472-6DA6EFB92663

Q33765608-C8C82B57-317B-4FF9-BAE3-03D6238623A0

Q33765608-EB0DD2DB-B355-4C66-AC94-35756BB2EA40

Q33765608-F4DB3552-0C04-4BC6-9A74-8CB46D5225B1

P2860

Q33765608-04A75B06-BB16-406A-8AF5-8A996B296532

Q33765608-267458CE-B43A-4E53-B786-0A86B758708D

Q33765608-36FD2281-D3BE-43A5-8C79-E6AA716C0704

Q33765608-5C24C5A0-A263-4830-AD62-BFDFFDEB2AFF

Q33765608-607DECBD-BAE6-4AB2-9EBA-2172B527ACCD

Q33765608-65D6B759-945A-49BE-A907-4157FECD0F3E

Q33765608-8D1633A9-ADD8-477B-A9F2-5D2EFAC9F712

Q33765608-91767C39-8F86-4526-895D-3EE9EA8D1171

Q33765608-BF8F3ED0-DE15-4DCF-B7BE-29593549CB80

Q33765608-C9F4D501-BF18-4138-9824-BC172A6E7851

P2888

Q33765608-EA07DCE4-F694-413C-BFE3-C2ECD4339028

P304

Q33765608-CD8FD9CD-4C44-4284-AD90-08CFB4DC0D1D

P31

Q33765608-F5FAA1E6-0063-40CF-A288-4EF092B15FC7

P356

Q33765608-0E8986DB-1D83-4320-9E6B-E5D65E76C7C2

P433

Q33765608-100619CD-A477-480C-BDD0-352D8158A5AA

P478

Q33765608-B9BC138E-AAF5-41C2-9FEA-3E2DA7717DDA

P50

Q33765608-1B321C12-340F-42CB-960D-153ACDA5DFA9

Q33765608-5415856F-4A92-42E9-8132-1233A05D7106

Q33765608-DEDB9E0D-2C31-465C-B22E-3BB124989689

P577

Q33765608-EDA40DC6-CF58-464A-ACC5-172D8ADFDC64

P5875

Q33765608-D4F1BBF0-2A62-4A53-9961-AC78959E621B

P6179

Q33765608-83767466-00D9-4184-A036-4FF71ACDEDA0

P698

Q33765608-0E20838E-F76D-48CA-88B7-F2B34213829C

P921

Q33765608-75C317F1-8999-46F2-A368-ADC11210FC49

P932

Q33765608-B7C7A2D8-623E-459E-8757-AC8DA5E33365

P356

P1433

Arthritis Research and Therapy

P1476

Rituximab in patients with rhe ...... tional study in 2,484 patients

@en

P2093

Andrea Rubbert-Roth

http://www.w3.org/2001/XMLSchema#string

Andreas Krause

http://www.w3.org/2001/XMLSchema#string

Constanze Richter

http://www.w3.org/2001/XMLSchema#string

Helmut Sörensen

http://www.w3.org/2001/XMLSchema#string

Iris Haug-Rost

http://www.w3.org/2001/XMLSchema#string

Joerg Wendler

http://www.w3.org/2001/XMLSchema#string

Peter Bartz-Bazzanella

http://www.w3.org/2001/XMLSchema#string

Siegfried Wassenberg

http://www.w3.org/2001/XMLSchema#string

Thomas Dörner

http://www.w3.org/2001/XMLSchema#string

P2860

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.

Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study.

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies

Treating rheumatoid arthritis to target: recommendations of an international task force.

Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients.

Optimising treatment in rheumatoid arthritis: a review of potential biological markers of response.

Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.

P2888

P304

R80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR4521

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Peter Tony

Gerd-Rüdiger Burmester

Andrea Rubbert-Roth

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261137033

http://www.w3.org/2001/XMLSchema#string

P6179

1052217745

http://www.w3.org/2001/XMLSchema#string

P698

24670196

http://www.w3.org/2001/XMLSchema#string

P921

multicenter trial

P932

4060207

http://www.w3.org/2001/XMLSchema#string